Right Dose, Right Now: Development of AutoKinetics for Real Time Model Informed Precision Antibiotic Dosing Decision Support at the Bedside of Critically Ill Patients
暂无分享,去创建一个
Tingjie Guo | Luca F. Roggeveen | Lucas M. Fleuren | Rob J. Bosman | Peter H. J. van der Voort | Armand R. J. Girbes | Paul Elbers | Ronald H. Driessen | Patrick Thoral | P. V. D. van der Voort | P. Elbers | R. Bosman | A. Girbes | L. Fleuren | Tingjie Guo | Luca F Roggeveen | P. Thoral | R. Driessen
[1] H. Mulla,et al. Personalised dosing of medicines for children , 2017, The Journal of pharmacy and pharmacology.
[2] J. Roberts,et al. Therapeutic drug monitoring of &bgr;-lactam antibiotics in the critically ill: direct measurement of unbound drug concentrations to achieve appropriate drug exposures , 2018, The Journal of antimicrobial chemotherapy.
[3] P. Elbers,et al. Clinically relevant pharmacokinetic knowledge on antibiotic dosing among intensive care professionals is insufficient: a cross-sectional study , 2019, Critical Care.
[4] Robert J Bauer,et al. NONMEM Tutorial Part I: Description of Commands and Options, With Simple Examples of Population Analysis , 2019, CPT: pharmacometrics & systems pharmacology.
[5] M. Levy,et al. Empiric Antibiotic Treatment Reduces Mortality in Severe Sepsis and Septic Shock From the First Hour: Results From a Guideline-Based Performance Improvement Program* , 2014, Critical care medicine.
[6] J. Mouton,et al. Meropenem Clinical Pharmacokinetics , 1995, Clinical pharmacokinetics.
[7] J. Lipman,et al. Antibiotic dose optimization in critically ill patients. , 2015, Medicina intensiva.
[8] R. Bax,et al. The human pharmacokinetics of cefotaxime and its metabolites and the role of renal tubular secretion on their elimination , 1985, Journal of Pharmacokinetics and Biopharmaceutics.
[9] Paul W G Elbers,et al. Right dose, right now: using big data to optimize antibiotic dosing in the critically ill. , 2014, Anaesthesiology intensive therapy.
[10] J. Kline,et al. Association between timing of antibiotic administration and mortality from septic shock in patients treated with a quantitative resuscitation protocol* , 2011, Critical care medicine.
[11] R. Bellomo,et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.
[12] P. V. D. van der Voort,et al. External Evaluation of Population Pharmacokinetic Models of Vancomycin in Large Cohorts of Intensive Care Unit Patients , 2019, Antimicrobial Agents and Chemotherapy.
[13] J. Rello,et al. DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients? , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] H. O. Oudemans-van Straaten,et al. Unexplained mortality differences between septic shock trials: a systematic analysis of population characteristics and control-group mortality rates , 2018, Intensive Care Medicine.
[15] M. Lustik,et al. Optimization of time to initial vancomycin target trough improves clinical outcomes , 2015, SpringerPlus.
[16] M. Samtani,et al. Pharmacokinetic-Pharmacodynamic-Model-Guided Doripenem Dosing in Critically Ill Patients , 2010, Antimicrobial Agents and Chemotherapy.
[17] Karl Aberer,et al. TUCUXI: An Intelligent System for Personalized Medicine from Individualization of Treatments to Research Databases and Back , 2017, BCB.
[18] B. Melton. Systematic Review of Medical Informatics–Supported Medication Decision Making , 2017, Biomedical informatics insights.
[19] Michael N Neely,et al. Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions. , 2014, The Lancet. Infectious diseases.
[20] J. D. De Waele,et al. Personalized antibiotic dosing for the critically ill , 2019, Intensive Care Medicine.
[21] A H Thomson,et al. Cost-Effectiveness of Therapeutic Drug Monitoring: A Systematic Review , 2005, Therapeutic drug monitoring.
[22] T. Buclin,et al. Benchmarking Therapeutic Drug Monitoring Software: A Review of Available Computer Tools , 2012, Clinical Pharmacokinetics.
[23] E. Tacconelli,et al. The pharmacokinetics and pharmacodynamics of vancomycin in clinical practice: evidence and uncertainties. , 2013, The Journal of antimicrobial chemotherapy.
[24] C. Runge. Ueber die numerische Auflösung von Differentialgleichungen , 1895 .
[25] User-Centered Design: Clothing The EMR Emperor , 2012 .
[26] K. Wood,et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock* , 2006, Critical care medicine.
[27] P. McNamara,et al. Pharmacokinetics of ceftriaxone following intravenous administration of a 3 g dose , 2004, European Journal of Clinical Pharmacology.
[28] M. Doogue,et al. Bayesian therapeutic drug monitoring software: past, present and future , 2018, International Journal of Pharmacokinetics.
[29] J. Roberts,et al. Antibiotic dose optimization in critically ill patients / Optimización de la dosis de antibióticos en pacientes críticamente enfermos , 2015 .
[30] J. Beney,et al. Clinical and economic outcomes of pharmaceutical services related to antibiotic use: a literature review , 2007, Pharmacy World & Science.
[31] D. Yealy,et al. Sepsis‐3 Septic Shock Criteria and Associated Mortality Among Infected Hospitalized Patients Assessed by a Rapid Response Team , 2018, Chest.
[32] Sarah P. Slight,et al. A systematic review of the types and causes of prescribing errors generated from using computerized provider order entry systems in primary and secondary care , 2017, AMIA.
[33] Richard Beale,et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008 , 2008 .
[34] J. Rotschafer,et al. Clinical Pharmacokinetics of Ciprofloxacin , 1990, Clinical pharmacokinetics.
[35] M. Puskarich,et al. The Impact of Timing of Antibiotics on Outcomes in Severe Sepsis and Septic Shock: A Systematic Review and Meta-Analysis* , 2015, Critical care medicine.
[36] Brian T. Tsuji,et al. The role of infection models and PK/PD modelling for optimising care of critically ill patients with severe infections , 2017, Intensive Care Medicine.
[37] T. van Gelder,et al. Clinical applications of population pharmacokinetic models of antibiotics: Challenges and perspectives , 2018, Pharmacological research.
[38] J. Rello,et al. Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients , 2014, Intensive Care Medicine.
[39] C. Seifert,et al. Timing and appropriateness of initial antibiotic therapy in newly presenting septic patients. , 2013, The American journal of emergency medicine.
[40] J. Roberts,et al. How do we use therapeutic drug monitoring to improve outcomes from severe infections in critically ill patients? , 2014, BMC Infectious Diseases.
[41] A. Huttner,et al. Therapeutic Drug Monitoring of Beta-Lactams and Other Antibiotics in the Intensive Care Unit: Which Agents, Which Patients and Which Infections? , 2018, Drugs.
[42] Felicia M Bowens,et al. Health information technology: integration of clinical workflow into meaningful use of electronic health records. , 2010, Perspectives in health information management.
[43] Michael P. Rogers. Python Tutorial , 2009 .
[44] J. Rello,et al. Does contemporary vancomycin dosing achieve therapeutic targets in a heterogeneous clinical cohort of critically ill patients? Data from the multinational DALI study , 2014, Critical Care.
[45] F. Jaimes,et al. Antimicrobial agent prescription: a prospective cohort study in patients with sepsis and septic shock , 2018, Tropical medicine & international health : TM & IH.
[46] Francesco Balena,et al. Programming Microsoft Visual Basic 6.0 , 1999 .
[47] Joyce Polessi,et al. The impact of each action in the Surviving Sepsis Campaign measures on hospital mortality of patients with severe sepsis/septic shock Impacto de cada ação dos pacotes da Surviving Sepsis Campaign na mortalidade hospitalar de pacientes portadores de sepse grave/choque séptico , 2008 .
[48] Anne Miller,et al. Integrating computerized clinical decision support systems into clinical work: A meta-synthesis of qualitative research , 2015, Int. J. Medical Informatics.
[49] Adil Rafiq Rather,et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) , 2015 .
[50] Albert Wambecq,et al. Rational Runge-Kutta methods for solving systems of ordinary differential equations , 2005, Computing.
[51] Munish Goyal,et al. Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department* , 2010, Critical care medicine.
[52] Stephan Harbarth,et al. Conserving antibiotics for the future: new ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective. , 2011, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.